These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 9399608)
21. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial. Pathak L; Hiremath ; Kerkar PG; Manade VG J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308 [TBL] [Abstract][Full Text] [Related]
22. [The safety of long-term administration of losartan in current clinical practice: a non-intervention NCT-CZ 14/04/LOZ study]. Krupicka J; Ceypová K; Kristenová P; Hauser T Vnitr Lek; 2008 Nov; 54(11):1031-8. PubMed ID: 19069675 [TBL] [Abstract][Full Text] [Related]
23. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension. Mistry GC; Maes AL; Lasseter KC; Davies MJ; Gottesdiener KM; Wagner JA; Herman GA J Clin Pharmacol; 2008 May; 48(5):592-8. PubMed ID: 18353996 [TBL] [Abstract][Full Text] [Related]
24. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial. Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480 [TBL] [Abstract][Full Text] [Related]
25. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group. McClennen W; Wilson T Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768 [TBL] [Abstract][Full Text] [Related]
26. [Effect of diltiazem on lipid profiles and heart rate in hypertensive patients]. Carré A; Joire JE; Mounier-Vehier C; Lequeuche B Ann Cardiol Angeiol (Paris); 1999 Mar; 48(3):221-6. PubMed ID: 12555384 [TBL] [Abstract][Full Text] [Related]
27. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years. Kisicki JC; Fiske K; Lyne A Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196 [TBL] [Abstract][Full Text] [Related]
28. Comparative antihypertensive effectiveness of once-daily mibefradil and diltiazem CD. Mibefradil Hypertension Study Group. Bittar N Clin Ther; 1997; 19(5):954-62. PubMed ID: 9385483 [TBL] [Abstract][Full Text] [Related]
29. Trial of slow release diltiazem for essential hypertension in general practice. Coulter DM N Z Med J; 1991 Feb; 104(905):37-8. PubMed ID: 1996187 [TBL] [Abstract][Full Text] [Related]
30. Effects of diltiazem or propranolol during exercise training of hypertensive men. Stewart KJ; Effron MB; Valenti SA; Kelemen MH Med Sci Sports Exerc; 1990 Apr; 22(2):171-7. PubMed ID: 2355813 [TBL] [Abstract][Full Text] [Related]
31. Antihypertensive efficacy of optimally titrated doses of once-daily sustained-release diltiazem: a placebo-controlled trial. DILPLACOMP Study Group. Ollivier JP; Wajman A; Stalla-Bourdillon A Cardiology; 1995; 86(6):481-7. PubMed ID: 7585759 [TBL] [Abstract][Full Text] [Related]
32. Renal effects of prolonged antihypertensive treatment with diltiazem. Tramonti G; Donadio C; Silvestri L; Caputo M; Lucchetti A; Giordani R; Bianchi C Kidney Int Suppl; 1996 Jun; 55():S78-80. PubMed ID: 8743517 [TBL] [Abstract][Full Text] [Related]
33. A placebo-controlled comparison of diltiazem and amlodipine monotherapy in essential hypertension using 24-h ambulatory monitoring. Watts RW; Wing LM Blood Press; 1998 Jan; 7(1):25-30. PubMed ID: 9551874 [TBL] [Abstract][Full Text] [Related]
34. [Hypotensive effect and characteristics of the effect on the central hemodynamics of the delayed-action form of diltiazem (Dilren) in patients with hypertension]. Pshenitsin AI; Glotov MN; Mazur NA Ter Arkh; 1993; 65(9):47-50. PubMed ID: 8303596 [TBL] [Abstract][Full Text] [Related]
35. [Ambulatory measurement of blood pressure and efficacy of diltiazem. Influence of the timing of drug ingestion and initial blood pressure level]. Bernard-Fernier MF; Renucci JF; Siche JP; Vaisse B; Poggi L; Mallion JM Ann Cardiol Angeiol (Paris); 1994 Jun; 43(6):357-64. PubMed ID: 8085776 [TBL] [Abstract][Full Text] [Related]
36. Antihypertensive efficacy and safe use of once-daily sustained-release diltiazem in the elderly: a comparison with captopril. The Dilcacomp Study Group. Nicaise J; Neveux E; Blondin P J Int Med Res; 1995; 23(4):244-53. PubMed ID: 7589767 [TBL] [Abstract][Full Text] [Related]
37. Diltiazem for treatment of essential hypertension: a double-blind controlled study with reserpine. Ogawa K; Ban M; Ito T; Watanabe T; Kobayashi T; Yamazaki N; Suzuki Y Clin Ther; 1984; 6(6):844-53. PubMed ID: 6391669 [TBL] [Abstract][Full Text] [Related]
38. Acute and short-term effects of nitrendipine and diltiazem at rest and during exercise in hypertensive patients. Gambini G; Valori C; Bianchi L; Bozza M Clin Ther; 1991; 13(6):680-6. PubMed ID: 1790542 [TBL] [Abstract][Full Text] [Related]
39. Optimization of antihypertensive therapy with a novel, extended-release formulation of diltiazem: results of a practice-based clinical study. Neutel JM; Smith DH; Frishman WH Clin Ther; 1997; 19(6):1379-93. PubMed ID: 9444447 [TBL] [Abstract][Full Text] [Related]